CCK8 Pep-LNP

Cat. No.: TDLD-0825-LD105

CCK8 Pep-LNP

CCK8 Pep-LNP is a state-of-the-art peptide-functionalized lipid nanoparticle (LNP), designed for efficient targeted delivery of therapeutic cargoes such as siRNA, mRNA, DNA, small molecule drugs, and RNA-guided gene editing systems. Engineered with the CCK8 peptide, this LNP specifically recognizes cell surface Cholecystokinin receptors (e.g., CCK2R), mediating receptor-mediated endocytosis to enhance cellular uptake efficiency and delivery precision into cell types expressing these receptors. Our LNP is prepared using DSPE-PEG-CCK8 and a variety of optional lipid formulations including DLin-MC3-DMA, LP-01, ALC-0315, SM102, and others. These formulations are carefully selected to ensure the LNP has uniform particle size, high encapsulation efficiency, stability, and targeted delivery. Applications of CCK8 Pep-LNP include developing targeted therapeutics for cancers or other diseases where CCK receptors are overexpressed, creating receptor-specific imaging probes, studying receptor-mediated endocytosis pathways, and evaluating novel strategies for precise drug or gene delivery to specific cell populations. Please note that this product is intended for research purposes only.